Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus

Clinical trial NCT02644759 · COMPLETED

Trial details

NCT number: NCT02644759
Sponsor: Stem Cells Arabia
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 1 Autoimmune Diseases Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases

Start date: 2014-02-01
Primary completion: 2017-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.